| Piramal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543635 |
NSE Symbol : PPLPHARMA |
P/E(TTM) : 33.38 |
|
ISIN Demat : INE0DK501011 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.82 |
|
Book Value(₹) : 61.18 |
Market Cap(₹Cr) : 25,868.09 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,782.01 | 5,285.71 | 4,390.11 | 3,443.22 | 3,340.42 |
| Other Income | 662.73 | 207.35 | 202.06 | 341.07 | 224.79 |
| Stock Adjustments | 138.98 | 84.57 | 61.62 | -53.31 | 32.66 |
| Total Income | 5,583.72 | 5,577.63 | 4,653.79 | 3,730.98 | 3,597.87 |
| EXPENDITURE : | |||||
| Raw Materials | 2,208.88 | 2,330.53 | 2,170.46 | 1,715.17 | 1,594.17 |
| Power and Fuel Cost | 131.53 | 131.62 | 112.89 | 107.94 | 83.83 |
| Other Manufacturing Expenses | 292.60 | 284.35 | 251.57 | 259.29 | 299.83 |
| Selling and Administration Expenses | 746.52 | 746.69 | 620.04 | 485.63 | 427.82 |
| Miscellaneous Expenses | 247.15 | 100.46 | 64.92 | 182.81 | 59.20 |
| Employee Benefit Expenses | 744.82 | 736.19 | 613.93 | 548.50 | 448.03 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,212.22 | 1,247.79 | 819.98 | 431.64 | 684.99 |
| Interest | 79.95 | 114.56 | 107.10 | 115.87 | 57.29 |
| Gross Profit | 1,132.27 | 1,133.23 | 712.88 | 315.77 | 627.70 |
| Depreciation | 255.50 | 222.09 | 205.26 | 192.08 | 165.37 |
| Profit Before Tax | 876.77 | 911.14 | 507.62 | 123.69 | 462.33 |
| Current Tax | 114.68 | 199.44 | 112.48 | 38.77 | 110.82 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 62.08 | 20.30 | 3.92 | 15.42 | -16.03 |
| Reported Net Profit | 700.01 | 691.40 | 391.22 | 69.50 | 367.54 |
| Extraordinary Items | -67.52 | 2.40 | 3.34 | -3.14 | -10.64 |
| Adjusted Net Profit | 767.53 | 689.00 | 387.88 | 72.64 | 378.18 |
| Adjustment below Net Profit | -13.89 | 1.05 | -3.79 | -2.59 | 31.70 |
| Profit/Loss Balance carried down | 2,037.21 | 1,359.23 | 971.79 | 918.28 | 569.04 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 18.54 | 14.47 | 0.00 | 13.40 | 50.00 |
| P & L Balance carried down | 2,704.79 | 2,037.21 | 1,359.22 | 971.79 | 918.28 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 1.40 | 1.10 | 0.00 | 5.60 |
| Dividend Per Share(Rs) | 0.00 | 0.14 | 0.11 | 0.00 | 0.56 |
| Earnings Per Share-Unit Curr | 5.27 | 5.22 | 2.96 | 0.58 | 3.10 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 61.34 | 56.27 | 50.74 | 44.09 | 43.20 |
| Book Value(Adj)-Unit Curr | 61.34 | 56.27 | 50.74 | 43.06 | - |
